Interface-targeted drug release driven by photoresponsive polyelectrolyte-surfactant complexes
Ipsita Pani1, Christina Spruck2, Michael Hardt1
1Institute of Physical Chemistry, University of Münster, Corrensstraße 28-30, 48149 Münster, Germany, Center for Soft Nanoscience (SoN), University of Münster, Busso-Peus-Straße 10, 48149 Münster, Germany.
Journal of Colloid and Interface Science
|September 28, 2025
Summary
Poly-l-lysine (PLL) enhances light-induced drug release from arylazopyrazole (AAP) nanocarriers. Optimal PLL concentrations improve doxorubicin (Dox) release to interfaces, exceeding that of AAP micelles alone.
Area of Science:
- Materials Science
- Biotechnology
- Chemical Engineering
Background:
- Photoresponsive surfactants enable controlled drug release.
- Aqueous-hydrophobic interfaces are relevant models for drug delivery.
- Polyelectrolytes can modify nanocarrier properties.
Purpose of the Study:
- To investigate poly-l-lysine (PLL) effects on arylazopyrazole (AAP) nanocarrier drug release.
- To optimize PLL concentration for enhanced doxorubicin (Dox) release to interfaces.
- To understand the mechanism of PLL-mediated drug release enhancement.
Main Methods:
- Formation of surfactant-polyelectrolyte complexes (PLL/AAP).
- Electrophoretic mobility and size measurements of complexes.
- Vibrational sum-frequency generation (SFG) spectroscopy of interfaces.
Main Results:
- PLL/AAP complexes show tunable net charge and colloidal stability.
- Optimal PLL concentration (ratio 0.5) significantly enhances Dox release to the interface.
- Dox release to the interface is accelerated by approximately 6-fold compared to AAP micelles alone.
Conclusions:
- PLL/AAP complexes offer enhanced control over light-induced drug release.
- Stable PLL/AAP complexes minimize surfactant competition, improving Dox adsorption.
- This approach shows promise for targeted chemotherapy delivery systems.
Keywords:
Drug releaseFluid interfacesNanocarriersPhotosurfactantsPolyelectrolyte-surfactant complexesMore Related Videos
Related Concept Videos
Bioavailability Enhancement: Drug Permeability Enhancement
163
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
163
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
174
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
174


